83_FR_39918 83 FR 39763 - HHS Approval of Entities That Certify Medical Review Officers

83 FR 39763 - HHS Approval of Entities That Certify Medical Review Officers

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 155 (August 10, 2018)

Page Range39763-39763
FR Document2018-17184

This notice publishes a list of the Department of Health and Human Services (HHS) approved Medical Review Officers certification entities. The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), applicable on October 1, 2017, addresses the role and qualifications of Medical Review Officers (MROs) and HHS approval of entities that certify MROs.

Federal Register, Volume 83 Issue 155 (Friday, August 10, 2018) 
[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Page 39763]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-17184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


HHS Approval of Entities That Certify Medical Review Officers

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice publishes a list of the Department of Health and 
Human Services (HHS) approved Medical Review Officers certification 
entities. The HHS Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (Mandatory Guidelines), applicable on October 1, 2017, 
addresses the role and qualifications of Medical Review Officers (MROs) 
and HHS approval of entities that certify MROs.

FOR FURTHER INFORMATION CONTACT: Sean J. Belouin, Pharm.D., CAPT, 
United States Public Health Service, Senior Pharmacology and Regulatory 
Policy Advisor, Substance Abuse and Mental Health Services 
Administration, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857; Telephone: (240) 276-2716; Email: [email protected].

SUPPLEMENTARY INFORMATION: Subpart M--Medical Review Officer (MRO), 
Section 13.2 of the Mandatory Guidelines, ``How are nationally 
recognized entities or subspecialty boards that certify MROs 
approved?'' states as follows: ``All nationally recognized entities or 
subspecialty boards which seek approval by the Secretary to certify 
physicians as MROs for federal workplace drug testing programs must 
submit their qualifications, a sample examination, and other necessary 
supporting examination materials (e.g., answers, previous examination 
statistics or other background examination information, if requested) 
(OMB Control No.: 0930-0158). Approval will be based on an objective 
review of qualifications that include a copy of the MRO applicant 
application form, documentation that the continuing education courses 
are accredited by a professional organization, and the delivery method 
and content of the examination. Each approved MRO certification entity 
must resubmit their qualifications for approval every two years. The 
Secretary shall publish at least every two years a notice in the 
Federal Register listing those entities and subspecialty boards that 
have been approved. This notice is also available on the internet at 
http://www.samhsa.gov/workplace/drug-testing.''
    HHS has completed its review of entities that certify MROs, in 
accordance with requests submitted by such entities to HHS.
    The HHS Secretary approves the following MRO certifying entities 
that offer MRO certification through examination:
American Association of Medical Review Officers (AAMRO), P.O. Box 
12873, Research Triangle Park, NC 27709, Phone: (919) 489-5407, Fax: 
(919) 490-1010, Email: [email protected], website: http://www.aamro.com/.
Medical Review Officer Certification Council (MROCC), 3231 S. Halsted 
St, #167, Chicago, IL 60608, Phone: (847) 631-0599, Fax: (847) 483-
1282, Email: [email protected], website: http://www.mrocc.org/.

DATES: HHS approval is effective July 31, 2018.

Alex M. Azar II,
Secretary.
[FR Doc. 2018-17184 Filed 8-9-18; 8:45 am]
 BILLING CODE 4162-20-P

Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices 39763 Washington, Center for Drug Evaluation Dated: August 6, 2018. resubmit their qualifications for and Research, Food and Drug Leslie Kux, approval every two years. The Secretary Administration, 10903 New Hampshire Associate Commissioner for Policy. shall publish at least every two years a Ave., Silver Spring, MD 20993–0002, [FR Doc. 2018–17130 Filed 8–9–18; 8:45 am] notice in the Federal Register listing 301–796–1019, tisha.washington@ BILLING CODE 4164–01–P those entities and subspecialty boards fda.hhs.gov no later than September 4, that have been approved. This notice is 2018. also available on the internet at http:// DEPARTMENT OF HEALTH AND www.samhsa.gov/workplace/drug- Requests for Oral Presentations: testing.’’ HUMAN SERVICES During online registration you may HHS has completed its review of indicate if you wish to present at the Substance Abuse and Mental Health entities that certify MROs, in public comment session, and which Services Administration accordance with requests submitted by topic(s) you wish to address. We will do such entities to HHS. our best to accommodate requests to HHS Approval of Entities That Certify The HHS Secretary approves the make public comments. Individuals and Medical Review Officers following MRO certifying entities that organizations with common interests are AGENCY: Substance Abuse and Mental offer MRO certification through urged to consolidate or coordinate their Health Services Administration, HHS. examination: presentations, and request time for a American Association of Medical ACTION: Notice. joint presentation. Following the close Review Officers (AAMRO), P.O. Box of registration, we will determine the SUMMARY: This notice publishes a list of 12873, Research Triangle Park, NC amount of time allotted to each the Department of Health and Human 27709, Phone: (919) 489–5407, Fax: presenter and the approximate time Services (HHS) approved Medical (919) 490–1010, Email: bbrandon@ each oral presentation is to begin, and Review Officers certification entities. aamro.com, website: http:// The HHS Mandatory Guidelines for www.aamro.com/. will select and notify participants by Medical Review Officer Certification September 5, 2018. All requests to make Federal Workplace Drug Testing Programs (Mandatory Guidelines), Council (MROCC), 3231 S. Halsted St, oral presentations must be received by #167, Chicago, IL 60608, Phone: (847) applicable on October 1, 2017, the close of registration on September 4, 631–0599, Fax: (847) 483–1282, addresses the role and qualifications of 2018. If selected for presentation, any Medical Review Officers (MROs) and Email: mrocc@mrocc.org, website: presentation materials must be emailed HHS approval of entities that certify http://www.mrocc.org/. to Tisha Washington (see FOR FURTHER MROs. DATES: HHS approval is effective July INFORMATION CONTACT) no later than 31, 2018. FOR FURTHER INFORMATION CONTACT: close of business, September 6, 2018. No Sean J. Belouin, Pharm.D., CAPT, Alex M. Azar II, commercial or promotional material United States Public Health Service, Secretary. will be permitted to be presented or Senior Pharmacology and Regulatory [FR Doc. 2018–17184 Filed 8–9–18; 8:45 am] distributed at the public workshop. Policy Advisor, Substance Abuse and BILLING CODE 4162–20–P Streaming Webcast of the Public Mental Health Services Administration, Workshop: This public workshop will 5600 Fishers Lane, Room 16N06D, also be webcast. The webcast link will Rockville, Maryland 20857; Telephone: DEPARTMENT OF HEALTH AND be available on the following web page (240) 276–2716; Email: sean.belouin@ HUMAN SERVICES 5 days before the workshop at: https:// samhsa.hhs.gov. www.fda.gov/Drugs/NewsEvents/ SUPPLEMENTARY INFORMATION: Subpart National Institutes of Health ucm611203.htm. M—Medical Review Officer (MRO), Section 13.2 of the Mandatory National Institute on Alcohol Abuse If you have never attended a Connect and Alcoholism; Notice of Meeting Pro event before, test your connection at Guidelines, ‘‘How are nationally https://collaboration.fda.gov/common/ recognized entities or subspecialty Pursuant to section 10(d) of the help/en/support/meeting_test.htm. To boards that certify MROs approved?’’ Federal Advisory Committee Act, as get a quick overview of the Connect Pro states as follows: ‘‘All nationally amended, notice is hereby given of a recognized entities or subspecialty meeting of the National Advisory program, visit https://www.adobe.com/ boards which seek approval by the Council on Alcohol Abuse and go/connectpro_overview. FDA has Secretary to certify physicians as MROs Alcoholism. verified the website addresses in this for federal workplace drug testing The meeting will be open to the document, as of the date this document programs must submit their public as indicated below, with publishes in the Federal Register, but qualifications, a sample examination, attendance limited to space available. websites are subject to change over time. and other necessary supporting Individuals who plan to attend and Transcripts: Please be advised that as examination materials (e.g., answers, need special assistance, such as sign soon as a transcript of the public previous examination statistics or other language interpretation or other workshop is available, it will be background examination information, if reasonable accommodations, should accessible at https:// requested) (OMB Control No.: 0930– notify the Contact Person listed below www.regulations.gov. It may be viewed 0158). Approval will be based on an in advance of the meeting. at the Dockets Management Staff (HFA– objective review of qualifications that The meeting will be closed to the daltland on DSKBBV9HB2PROD with NOTICES 305), Food and Drug Administration, include a copy of the MRO applicant public in accordance with the 5630 Fishers Lane, Rm. 1061, Rockville, application form, documentation that provisions set forth in sections MD 20852. A link to the transcript will the continuing education courses are 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., also be available on the internet at accredited by a professional as amended. The grant applications and https://www.fda.gov/Drugs/NewsEvents/ organization, and the delivery method the discussions could disclose and content of the examination. Each confidential trade secrets or commercial ucm611203.htm. approved MRO certification entity must property such as patentable material, VerDate Sep<11>2014 19:03 Aug 09, 2018 Jkt 244001 PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 E:\FR\FM\10AUN1.SGM 10AUN1


Document Created: 2018-08-10 01:56:42
Document Modified: 2018-08-10 01:56:42
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesHHS approval is effective July 31, 2018.
ContactSean J. Belouin, Pharm.D., CAPT, United States Public Health Service, Senior Pharmacology and Regulatory Policy Advisor, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857; Telephone: (240) 276-2716; Email: [email protected]
FR Citation83 FR 39763 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR